SOURCE: QRSciences Holdings Limited

July 13, 2005 13:28 ET

QRSciences in U.S. Homeland Security Spotlight

SAN DIEGO, CA -- (MARKET WIRE) -- July 13, 2005 -- QRSciences (OTC: QRSHY) (ASX: QRS), a world leader in the development of Quadrupole Resonance (QR), today announces that QXR 1000, a project the company has been working on for the past nine months in association with Rapiscan Systems, a wholly owned subsidiary of Los Angeles-based OSI Systems, will come under the spotlight of the United States House of Representatives Committee on Homeland Security.

QXR 1000 adds a wholly new layer of explosive detection functionality to X-Ray systems deployed at approximately half of all carry-on checkpoints at U.S. airports.

Kevin Russeth, Chief Executive Officer of QRSciences Inc., comments, "Testimony today will highlight the importance of installing new systems at the nation's airports that significantly enhance the probability of detection, are cost effective, and minimize inconvenience to the travelling public.

"We take pride in our close association with OSI Systems and its subsidiary Rapiscan, and believe strongly that the marriage between X-Ray and QR provides a hybrid solution that is second to none in terms of capability in preventing weapons (including explosive devices) being smuggled aboard airliners."

Testimony will be given by Deepak Chopra, Chairman and CEO of OSI Systems, Inc., a leading supplier of detection systems globally. The testimony will outline technologies offered by OSI subsidiary Rapiscan Systems, including the QXR 1000, which incorporates QRSciences next generation QR and metal detection technology.

The House of Representatives Committee on Homeland Security is expected to convene at 2:00pm EDT on Wednesday, July 13, 2005, and can be viewed on C-SPAN at that time.

About QRSciences:

QRSciences Corporation, based in San Diego, California, is a wholly owned subsidiary of QRSciences Holdings Limited headquartered in Perth, Western Australia. The company designs and develops systems, sub-systems, components and software for security related applications. QRSciences is a developer of advanced technology and leader in the field of Quadrupole Resonance (QR), a next-generation technology that uses radio frequency spectroscopy techniques to detect and positively identify a wide range of materials. Applications for the technologies include explosive and narcotic detection, pharmaceutical quality control and assurance, mineral and material assay, lab instrumentation and environmental science.

For more information about QRSciences, please visit: http://www.qrsciences.com.

About OSI Systems:

OSI Systems, Inc. is a diversified global developer, manufacturer and seller of optoelectronic-based components and systems. The Company has over 30 years of optoelectronics experience, and through its family of subsidiaries, competes in four specific growth areas: OEM Manufacturing, Security through its subsidiary Rapiscan Systems, Medical, and Fiber Optics.

By leveraging its core expertise in Optoelectronics and Electromechanical Sensor technology design, development and manufacturing capabilities, and through vertical integration and global manufacturing and sales presence, the Company aim to lead the industry in providing the best, most advanced, and lowest cost products to the world.

For more information about OSI Systems please visit:

http://www.osi-systems.com or to view a recent OSI news release
http://www.osi-systems.co.in/osinews/osinews.aspx?newsid=1036
Forward-Looking Statements

The discussion above contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements by their nature involve substantial risks and uncertainties. Actual results may differ materially depending on a variety of factors.

Contact Information

  • Contacts
    Mr. Kevin Russeth, CEO
    QRSciences Holdings Limited
    Email Contact
    + 1-858-345-1095

    Investor Relations
    Richard Cooper/ Jennifer K. Zimmons, Ph.D.
    Strategic Growth International, Inc.
    Email Contact
    + 1-212-838-1444